Sign in

CIK 0001622229

  • Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465308248
Phone
+1 617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,689,493
in 1 filing, $1.7M under 10b5-1 plans

Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Morris Arlene −$1.7M Director sold 100% of stake

Reading 18 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-09 Shegog Todd Director Grant or award · Stock Option (Right to Buy) +17,901 17,901
2025-06-04 Shegog Todd Director Grant or award · Stock Option (Right to Buy) +44,700 44,700
2024-06-05 Shegog Todd Director Grant or award · Stock Option (Right to Buy) +44,700 44,700
2023-06-07 Shegog Todd Director Grant or award · Stock Option (Right to Buy) +36,700 36,700
2022-06-07 Shegog Todd Director Grant or award · Stock Option (Right to Buy) +30,700 30,700
2021-03-11 Shegog Todd Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-02-22 Shegog Todd Director Grant or award · Stock Option (Right to Buy) +37,500 37,500

Page 1 of 1 · 7 trades